Skip to main content

Published locations for FDA approves pembrolizumab/lenvatinib combo for advanced endometrial carcinoma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves pembrolizumab/lenvatinib combo for advanced endometrial carcinoma

User login

  • Reset your password
  • /content/fda-approves-pembrolizumab/lenvatinib-combo-advanced-endometrial-carcinoma
  • /obgynnews/article/208299/gynecologic-cancer/fda-approves-pembrolizumab/lenvatinib-combo-advanced
  • /oncologypractice/article/208299/gynecologic-cancer/fda-approves-pembrolizumab/lenvatinib-combo
  • /obgyn/article/208299/gynecologic-cancer/fda-approves-pembrolizumab/lenvatinib-combo-advanced
  • /hematology-oncology/article/208299/gynecologic-cancer/fda-approves-pembrolizumab/lenvatinib-combo